Atrial fibrillation Circulatory System
Conditions
Interventions
Eligible participants will be identified via an electronic search of GP practice data, identifying individuals with risk factors (such as diabetes or high blood pressure) that put them at an increased
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male or Female, aged > = 65 years old. 2. CHA2DS2-VASc score > = 3 in men or > = 4 in women. 3. Willing and able to give informed consent for participation in the study.
Exclusion criteria
Exclusion criteria: 1. Known to have AF or atrial flutter 2. Latex allergy (given the potential for an allergic reaction to the Zio Patch)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of 2 weeks of continuous monitoring using Zio Patch on the proportion of participants diagnosed with AF compared to usual care at 2.5 years of follow up from randomization (i.e. at around the midpoint of a proposed 5-year screening interval). | — |
Secondary
| Measure | Time frame |
|---|---|
| Following the initial phase, all participants will continue with their normal care. At 1, 2½ and 5 years after randomization data will be collected from the GP records to assess the proportion of participants diagnosed with AF (as recorded in the electronic GP record) and to see if having AF diagnosed earlier, made a difference to their medical care and stroke rate. | — |
Countries
England, United Kingdom
Outcome results
None listed